517 articles
J.G. Heathcote
J.G. Heathcote is a British biochemist who researched oral vitamin B12 treatment of pernicious anemia at St Helens Hospital and the University of Salford, publishing from 1958 to 1976.
Jacek Hawiger
Jacek "Jack" Hawiger is a Polish-born American physician-scientist at Vanderbilt University Medical Center whose research spans vascular biology and inflammation, from 1975 platelet and fibrinogen biochemistry in Nature to peptide drugs blocking inflammatory transcription factors.
Jack Hirsh
Jack Hirsh (born January 7, 1935, in Melbourne) is an Australian-born physician-scientist at McMaster University whose work on heparin monitoring and the INR shaped anticoagulant therapy.
Jacob Furth
Jacob Furth (1896–1979) was an American experimental pathologist who built the first experimental leukemia system in mammals and was elected to the National Academy of Sciences in 1974.
James Bruce Bussel
James Bruce Bussel, also known as James B. Bussel, is an American pediatric hematologist at Weill Cornell Medicine who defined the modern treatment of fetal alloimmune thrombocytopenia.
James D. Griffin
James D. Griffin is a physician-scientist at Harvard Medical School and Dana-Farber Cancer Institute in Boston whose leukemia research helped develop the targeted kinase inhibitors nilotinib and midostaurin.
James H. Jandl
James H. Jandl (1925–2006) was an American experimental hematologist who spent his career at Harvard in Boston, defining how red blood cells age and writing the textbook Blood: Textbook of Hematology.
James L. Tullis
James Lyman Tullis (1914–1996) was an American physician and blood researcher at New England Deaconess Hospital in Boston who identified leukocyte and platelet antibodies behind transfusion reactions and purpura.
James N. Ihle
James N. Ihle is an American biochemist who spent most of his career at St. Jude Children's Research Hospital, discovered interleukin-3 in 1981, and defined the JAK-STAT cytokine signaling pathway.
Jamés O. Armitage
James O. Armitage is a hematology-oncology physician and Joe Shapiro Professor at the University of Nebraska Medical Center who founded its blood and bone marrow transplant program in 1982.
James P. Kushner
James P. Kushner is an American physician-scientist in hematology at the University of Utah, an internationally recognized authority on hereditary hemochromatosis and the porphyrias who retired in 2011.
James S. Wainscoat
James S. Wainscoat, also recorded as J.S. Wainscoat, is a consultant haematologist and Oxford professor known for DNA-based prenatal diagnosis of β-thalassaemia and fetal RhD genotyping.
Jan A. Burger
Jan A. Burger is a German-trained hematologist and professor at MD Anderson Cancer Center who studies chronic lymphocytic leukemia and led the RESONATE-2 trial of ibrutinib.
Jan Cools
Jan Cools is a Belgian leukemia genetics researcher and full professor at KU Leuven, known for identifying FIP1L1-PDGFRA as imatinib's target in hypereosinophilic syndrome and for the NUP214-ABL1 oncogene in T-ALL.
Jan G. Waldenström
Jan Gösta Waldenström (1906–1996) was a Swedish physician and medical researcher, professor of internal medicine at Lund University, who first described Waldenström macroglobulinemia and classified gammopathies as monoclonal or polyclonal.
Jan W. ten Cate
Jan W. ten Cate (Jan Wouter ten Cate, 1939–2020) was a Dutch internist and hematologist at the University of Amsterdam whose work fixed how deep-vein thrombosis is diagnosed and treated.
Jan‐Inge Henter
Jan-Inge Henter (born 1953) is a Swedish pediatric hematologist-oncologist and professor at Karolinska Institutet in Stockholm, known for defining hemophagocytic lymphohistiocytosis (HLH) and leading the international HLH-94 and HLH-2004 treatment studies.
Jane E. Freedman
Jane E. Freedman is an American physician-scientist whose research centers on platelets, thrombosis, and immunity in cardiovascular disease; she chairs Vanderbilt University Medical Center's Department of Medicine.
Jason Gotlib
Jason R. Gotlib is an American hematologist-oncologist and Stanford professor of medicine whose clinical trials led to FDA approval of midostaurin and avapritinib for advanced systemic mastocytosis.
Jay L. Degen
Jay L. Degen is a hematologist and mouse geneticist at Cincinnati Children's Hospital and the University of Cincinnati, known for using gene-targeted mice to define what blood-clotting and clot-dissolving proteins do.
Jayachandran N. Kizhakkedathu
Jayachandran N. Kizhakkedathu, also published as Jayachandran Kizhakkedathu, is a polymer chemist and biomaterials researcher at the University of British Columbia who designs blood-compatible surfaces and synthetic anticoagulants.
Jean Bernard (physician)
Jean Bernard (1907–2006) was a French physician and hematologist who helped establish that some acute leukemias could be cured, built French hematology at Saint-Louis Hospital, and led France's bioethics committee.
Jean D. Ross
Jean D. Ross was a researcher in pediatrics and hematology at Tufts Children's Hospital and Tufts University, known for work on infant iron-deficiency anemia and newborn methemoglobinemia.
Jean Pierre Soulier
Jean Pierre Soulier (1915–2003) was a French physician and hematologist who directed the Centre national de transfusion sanguine from 1954 to 1984 and helped identify the two forms of hemophilia.
Jean Rosa
Jean Rosa (1927–2025) was a French physician-scientist in hematology and red-cell biochemistry who identified hemoglobin variants, pioneered prenatal diagnosis of sickle cell disease in France, and led an INSERM research unit at the Hôpital Henri Mondor.
Jean‐Pierre Cartron
Jean-Pierre Cartron is a French biochemist and physician-scientist at the Institut national de transfusion sanguine in Paris, known for defining the molecular basis of human blood group systems.
Jeffrey I. Weitz
Jeffrey I. Weitz, also known as Jeffrey Weitz, is a Canadian hematologist at McMaster University who studies blood coagulation and led trials of anticoagulant drugs including milvexian.
Jeffrey L. Carson
Jeffrey L. Carson is an American internal medicine physician-researcher and Distinguished Professor at Rutgers Robert Wood Johnson Medical School who led the FOCUS and MINT trials of blood transfusion thresholds.
Jeffrey S. Ginsberg
Jeffrey S. Ginsberg, also known as Jeffrey Ginsberg, was a Canadian internist and thrombosis researcher at McMaster University known for research on venous thromboembolism and thrombosis in pregnancy.
Jennifer R. Brown
Jennifer R. Brown is an American physician-scientist who directs the CLL Center at Dana-Farber Cancer Institute and led the ALPINE and AMPLIFY trials that shaped targeted CLL treatment.